Found: 37
Select item for more details and to access through your institution.
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens.
- Published in:
- International Journal of Oncology, 2015, v. 46, n. 1, p. 55, doi. 10.3892/ijo.2014.2699
- By:
- Publication type:
- Article
A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin.
- Published in:
- BJU International, 2011, v. 108, n. 6, p. 831, doi. 10.1111/j.1464-410X.2010.09933.x
- By:
- Publication type:
- Article
A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients with HCV with various HLA class IA alleles.
- Published in:
- Journal of Medical Virology, 2009, v. 81, n. 7, p. 1232, doi. 10.1002/jmv.21518
- By:
- Publication type:
- Article
Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
STAT1 Mutations in Chronic Mucocutaneous Candidiasis Diagnosed in an Adult.
- Published in:
- Internal Medicine, 2024, v. 63, n. 9, p. 1269, doi. 10.2169/internalmedicine.2350-23
- By:
- Publication type:
- Article
Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b<sup>+</sup> HLA-A24<sup>+</sup> patients
- Published in:
- Hepatology Research, 2005, v. 32, n. 4, p. 227, doi. 10.1016/j.hepres.2005.06.003
- By:
- Publication type:
- Article
Humoral Immune Responses to EGFR-Derived Peptides Predict Progression-Free and Overall Survival of Non-Small Cell Lung Cancer Patients Receiving Gefitinib.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086667
- By:
- Publication type:
- Article
Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2013, v. 2013, p. 1, doi. 10.1155/2013/981717
- By:
- Publication type:
- Article
Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2001, doi. 10.1007/s00262-020-02599-4
- By:
- Publication type:
- Article
Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1565, doi. 10.1007/s00262-015-1756-7
- By:
- Publication type:
- Article
Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 493, doi. 10.1007/s00262-015-1660-1
- By:
- Publication type:
- Article
A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1001, doi. 10.1007/s00262-010-0822-4
- By:
- Publication type:
- Article
Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1845, doi. 10.1007/s00262-009-0695-6
- By:
- Publication type:
- Article
An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 alleles.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1879, doi. 10.1007/s00262-009-0699-2
- By:
- Publication type:
- Article
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1359, doi. 10.1007/s00262-007-0284-5
- By:
- Publication type:
- Article
Toxic potential of the raphidophyte Olisthodiscus luteus: mediation by reactive oxygen species.
- Published in:
- Journal of Plankton Research, 1999, v. 21, n. 6, p. 1017, doi. 10.1093/plankt/21.6.1017
- By:
- Publication type:
- Article
Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females.
- Published in:
- Experimental & Therapeutic Medicine, 2017, v. 13, n. 4, p. 1500, doi. 10.3892/etm.2017.4150
- By:
- Publication type:
- Article
Depletion of Intracellular NAD+ and ATP Levels during Ricin-Induced Apoptosis through the Specific Ribosomal Inactivation Results in the Cytolysis of U937 Cells.
- Published in:
- Journal of Biochemistry, 2000, v. 128, n. 3, p. 463, doi. 10.1093/oxfordjournals.jbchem.a022775
- By:
- Publication type:
- Article
Specific Efflux of Glutathione from the Basolateral Membrance Domain in Polarized MDCK Cells during Ricin-Induced Apoptosis.
- Published in:
- Journal of Biochemistry, 1999, v. 126, n. 4, p. 715, doi. 10.1093/oxfordjournals.jbchem.a022508
- By:
- Publication type:
- Article
Haptoglobin Proved a Prognostic Biomarker in Peripheral Blood of Patients with Personalized Peptide Vaccinations for Advanced Castration-Resistant Prostate Cancer.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2013, v. 77, n. 4, p. 766, doi. 10.1271/bbb.120893
- By:
- Publication type:
- Article
Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients.
- Published in:
- Prostate, 2008, v. 68, n. 16, p. 1753, doi. 10.1002/pros.20847
- By:
- Publication type:
- Article
Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients.
- Published in:
- International Journal of Oncology, 2020, v. 56, n. 6, p. 1479, doi. 10.3892/ijo.2020.5019
- By:
- Publication type:
- Article
A Correlation between Symptom Severity and Unbalanced Reactive IgA Production in Japanese Cedar Pollinosis Patients.
- Published in:
- Asian Pacific Journal of Allergy & Immunology, 2008, v. 26, n. 2/3, p. 97
- By:
- Publication type:
- Article
Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 12, p. 3208, doi. 10.1002/cncr.26636
- By:
- Publication type:
- Article
Integrity of plasma cell-free DNA as a prognostic factor for vaccine therapy in patients with endometrial cancer.
- Published in:
- Molecular & Clinical Oncology, 2021, v. 14, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides.
- Published in:
- Virology Journal, 2012, v. 9, n. 1, p. 199, doi. 10.1186/1743-422X-9-199
- By:
- Publication type:
- Article
Tumor‐derived mitochondrial formyl peptides suppress tumor immunity through modification of the tumor microenvironment.
- Published in:
- Cancer Science, 2024, v. 115, n. 10, p. 3218, doi. 10.1111/cas.16266
- By:
- Publication type:
- Article
CD4/CD8 ratio is a prognostic factor in IgG nonresponders among peptide vaccine‐treated ovarian cancer patients.
- Published in:
- Cancer Science, 2020, v. 111, n. 4, p. 1124, doi. 10.1111/cas.14349
- By:
- Publication type:
- Article
Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients.
- Published in:
- Cancer Science, 2016, v. 107, n. 5, p. 590, doi. 10.1111/cas.12919
- By:
- Publication type:
- Article
PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer.
- Published in:
- Cancer Science, 2014, v. 105, n. 10, p. 1229, doi. 10.1111/cas.12502
- By:
- Publication type:
- Article
Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer.
- Published in:
- Cancer Science, 2012, v. 103, n. 4, p. 638, doi. 10.1111/j.1349-7006.2012.02202.x
- By:
- Publication type:
- Article
Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination.
- Published in:
- Cancer Science, 2010, v. 101, n. 10, p. 2110, doi. 10.1111/j.1349-7006.2010.01653.x
- By:
- Publication type:
- Article
Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer.
- Published in:
- Cancer Science, 2010, v. 101, n. 3, p. 601, doi. 10.1111/j.1349-7006.2009.01459.x
- By:
- Publication type:
- Article
Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients.
- Published in:
- Cancer Science, 2009, v. 100, n. 11, p. 2167, doi. 10.1111/j.1349-7006.2009.01298.x
- By:
- Publication type:
- Article
Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles.
- Published in:
- Cancer Science, 2009, v. 100, n. 10, p. 1935, doi. 10.1111/j.1349-7006.2009.01256.x
- By:
- Publication type:
- Article
Effect of the Hemolytic Lectin CEL-III from Holothuroidea Cucumaria echinata on the ANS Fluorescence Responses in Sensitive MDCK and Resistant CHO Cells.
- Published in:
- Journal of Biochemistry, 1999, v. 125, n. 4, p. 713, doi. 10.1093/oxfordjournals.jbchem.a022341
- By:
- Publication type:
- Article
Involvement of Both Caspase-Like Proteases and Serine Proteases in Apoptotic Cell Death Induced by Ricin, Modeccin, Diphtheria Toxin, and Pseudomonas Toxin.
- Published in:
- Journal of Biochemistry, 1998, v. 124, n. 5, p. 1038, doi. 10.1093/oxfordjournals.jbchem.a022197
- By:
- Publication type:
- Article